Amy L Gordin, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 89 Notch Shopping Center Lane, Branson West, MO 65737 Phone: 417-338-9355 Fax: 417-338-2701 |
Bryce A Huddleston Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 16282 State Highway 13 Ste F, Branson West, MO 65737 Phone: 417-272-3909 Fax: 417-272-3918 |
Lindsey Grace Hejlek, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 16914 Mo-13, Branson West, MO 65737 Phone: 417-272-3909 |
News Archive
A Columbia University Medical Center-led research team has clinically validated a new method for predicting time to full-time care, nursing home residence, or death for patients with Alzheimer's disease.
Scientists at Washington University School of Medicine in St. Louis have identified a substance in the liver that helps process fat and glucose. That substance is a component of the common food additive lecithin, and researchers speculate it may one day be possible to use lecithin products to control blood lipids and reduce risk for diabetes, hypertension or cardiovascular disease using treatments delivered in food rather than medication.
The way doctors, hospitals and other health care providers are paid creates a so-called "perverse incentive" to order more and more medical services, even when those services do not contribute to better health, according to researchers for Dartmouth's Atlas of Health, CNN's investigations unit reports. The report explores a lawsuit filed against a physician-owned hospital in McAllen, Texas, by one of the physician-owners.
CSL Biotherapies welcomed news overnight of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that top-line data from part one of a two-part Phase 1 study of SPI-1620 in combination with docetaxel was presented in an oral presentation at the 12th International Conference on Endothelin, held in Cambridge, United Kingdom, from September 11-14, 2011. Part one of the study has been completed, while part two is ongoing.
› Verified 5 days ago